CardioFocus Overview

  • Year Founded
  • 1990

Year Founded

  • Status
  • Private

  • Employees
  • 70

Employees

  • Latest Deal Type
  • Series CC

  • Latest Deal Amount
  • $27.2M

  • Investors
  • 13

CardioFocus General Information

Description

Developer of medical devices designed to bring precision and control to the treatment of atrial fibrillation. The company's devices consist of a balloon catheter, endoscope, deflectable sheath and integrated console, that together form a system offering direct visualization, titratable energy delivery and universal balloon design, enabling physicians to perform pulmonary vein isolation procedures with accuracy and precision as well as to customize the amount of energy used for their ablations, based upon patients' specific needs.

Contact Information

Website
www.cardiofocus.com
Formerly Known As
Rare Earth Medical
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 500 Nickerson Road
  • Suite 500-200
  • Marlborough, MA 01752
  • United States
+1 (508)
Primary Industry
Surgical Devices
Other Industries
Therapeutic Devices
Vertical(s)
LOHAS & Wellness, HealthTech, Life Sciences
Corporate Office
  • 500 Nickerson Road
  • Suite 500-200
  • Marlborough, MA 01752
  • United States
+1 (508)

CardioFocus Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CardioFocus Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
23. Later Stage VC (Series CC) 23-Feb-2023 $27.2M Completed Generating Revenue
22. Secondary Transaction - Private 01-Jun-2022 Completed Generating Revenue
21. Later Stage VC (Series BB) 12-Apr-2022 Completed Generating Revenue
20. Secondary Transaction - Private Completed Generating Revenue
19. Later Stage VC 20-Jul-2020 Completed Generating Revenue
18. Debt - PPP 28-Apr-2020 Completed Generating Revenue
17. Debt - General 02-Mar-2020 Completed Generating Revenue
16. Later Stage VC 28-May-2019 Completed Generating Revenue
15. Debt - General 22-Jun-2018 $21M $183M Completed Generating Revenue
14. Debt - General $170M Completed Generating Revenue
To view CardioFocus’s complete valuation and funding history, request access »

CardioFocus Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series CC
Series BB
Series AA 12,385,000 $0.001000 $1 $1 1x $1 26.99%
To view CardioFocus’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

CardioFocus Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of medical devices designed to bring precision and control to the treatment of atrial fibrillation. The compan
Surgical Devices
Marlborough, MA
70 As of 2025

Sydney, Australia
 

Baldwin, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CardioFocus Competitors (13)

One of CardioFocus’s 13 competitors is CathRX, a Venture Capital-Backed company based in Sydney, Australia.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CathRX Venture Capital-Backed Sydney, Australia
Elliquence Corporate Backed or Acquired Baldwin, NY
Kimal Corporate Backed or Acquired Worcester, United Kingdom
InfoBionic.Ai Venture Capital-Backed Chelmsford, MA
Cook Medical Private Equity-Backed Bloomington, IN
You’re viewing 5 of 13 competitors. Get the full list »

CardioFocus Patents

  • 212

    Total Documents Applications and Grants

  • Total Patents Families

  • 79

    Granted

  • 26

    Pending

  • Expiring in next 12 mo

CardioFocus Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240390053-A1 Deployable structures to provide electrodes on the surface of an endoscopically guided laser ablation catheter for use in ablation and electrophysiological mapping Pending 26-May-2023
US-20240325066-A1 Local impedance indicator in the treatment of cardiac tissue Pending 31-Mar-2023
US-20240407836-A1 Acute assessment of cardiac ablatoin lesions Pending 23-Nov-2021
AU-2022396157-A1 Acute assessment of cardiac ablation lesions Pending 23-Nov-2021
CA-3238719-A1 Acute assessment of cardiac ablation lesions Pending 23-Nov-2021 A61B18/1492
To view CardioFocus’s complete patent history, request access »

CardioFocus Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CardioFocus Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Schroders Asset Manager Minority
Biobrit Venture Capital Minority
BioMed Realty Real Estate Minority
Revelation Partners Venture Capital Minority
Saints Capital Secondary Buyer Minority
You’re viewing 5 of 13 investors. Get the full list »

CardioFocus Acquisitions (1)

CardioFocus’s most recent deal was a Merger/Acquisition with Galvanize Therapeutics (Electrophysiology Technology Division). The deal was made on 10-Jan-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Galvanize Therapeutics (Electrophysiology Technology Division) 10-Jan-2024 Merger/Acquisition Therapeutic Devices
To view CardioFocus’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

CardioFocus FAQs

  • When was CardioFocus founded?

    CardioFocus was founded in 1990.

  • Where is CardioFocus headquartered?

    CardioFocus is headquartered in Marlborough, MA.

  • What is the size of CardioFocus?

    CardioFocus has 70 total employees.

  • What industry is CardioFocus in?

    CardioFocus’s primary industry is Surgical Devices.

  • Is CardioFocus a private or public company?

    CardioFocus is a Private company.

  • What is the current valuation of CardioFocus?

    The current valuation of CardioFocus is .

  • What is CardioFocus’s current revenue?

    The current revenue for CardioFocus is .

  • How much funding has CardioFocus raised over time?

    CardioFocus has raised $324M.

  • Who are CardioFocus’s investors?

    Schroders, Biobrit, BioMed Realty, Revelation Partners, and Saints Capital are 5 of 13 investors who have invested in CardioFocus.

  • Who are CardioFocus’s competitors?

    CathRX, Elliquence, Kimal, InfoBionic.Ai, and Cook Medical are some of the 13 competitors of CardioFocus.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »